Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Migraine Medication Effects on Urinary Symptoms

NCT06212661 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06212661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06212661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Migraine Medication Effects on Urinary Symptoms
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 5, 2024
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder pain syndrome, interstitial cystitis, migraine, migraine disorders, overactive bladder, overactive bladder syndrome, overactive detrusor